Source: Annual Congress 2012 - New biomarkers for lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Jareno Esteban, M. A. Munoz Lucas, B. Carrillo Aranda, J. A. Maldonado Sanz, C. Civera Tejuca, A. Aguilar Ros, G. Rodriguez Trigo, C. Gutierrez Ortega, J. L. Alvarez Sala, L. Callol Sanchez (Madrid, Spain). Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases. Eur Respir J 2012; 40: Suppl. 56, 4204

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Standardization of exhaled volatile organic compounds (VOCs) measurement Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation Year: 2012 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Exhaled volatile organic compounds in nonrespiratory diseases Source: Eur Respir Monogr 2010; 49: 140-151 Year: 2010 The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds Source: Eur Respir J 2005; 26: Suppl. 49, 373s Year: 2005 Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Comprehensive analysis of volatile organic compounds in human breath gas samples Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Fractionated investigation of gaseous compounds in exhaled breath with a GC/IMS-system Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Design of accurate COPD classification model based on volatile organic compounds from exhaled air Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008